In our sample, in order to further investigate the potential beneficial effects of ACE inhibitors, the impact of which might be larger in patients with diabetes, COPD, or cardiovascular diseases, we performed additional analyses, stratified by comorbidities. This evidence concerns the gene ACE and chronic obstructive pulmonary disease.